Overall, in our study, 2.3% of malignant ovarian tumors harbored MMR gene variant (excluding VUS), which is almost concordant with a previous report that ovarian cancer has 1.3%–5% of MMR gene variant.13, 14. This evidence concerns the gene MRC1 and cancer.